Cristal Therapeutics announces appointment of Jeroen Tonnaer as Chief Business Officer
Maastricht, The Netherlands, 21 April 2015 – Cristal Therapeutics, a privately-held life sciences company developing novel nanotherapeutics against cancer and other diseases, by using its patented CriPec® platform announced today the appointment of Jeroen Tonnaer as new Chief Business Officer responsible for Cristal Therapeutics’ business development, partnering and licensing activities. Jeroen obtained an MSc in […]